Skip to main content

Table 1 Baseline demographic and clinical characteristics, biomarkers and HRQOL scores

From: Cardiac biomarkers and health-related quality of life in new hemodialysis patients without symptomatic cardiac disease

Age (yrs); median (25th to 75th percentiles) 51.5 (39 to 62)
Female; N (%) 236 (39.6)
Non-white race; N (%) 63 (10.6)
Cause of ESRD:  
 Glomerulonephritis; N (%) 171 (28.7)
 Diabetic Nephropathy; N (%) 106 (17.8)
 Polycistic kidney disease; N (%) 54 (9.1)
 Hypertension; N (%) 48 (8.1)
 Other/Unknown; N (%) 217 (36.4)
Dialysis duration (mo); median (25th to 75th percentiles) 9 (6 to 14)
Dialysis access:  
 Fistula; N (%) 502 (84.2)
 Graft; N (%) 33 (5.5)
 Catheter; N (%) 61 (10.2)
Assigned to high Hb target; N (%) 296 (49.7)
Epoetin dosage (U/wk); median (25th to 75th percentiles); n = 584 6000 (4000 to 8000)
BMI (kg/m2); median (25th to 75th percentiles) 25.5 (22.6 to 29.3)
Systolic BP (mmHg); median (25th to 75th percentiles); n = 595 140 (130 to 158)
Diastolic BP (mmHg); median (25th to 75th percentiles); n = 596 80 (71 to 90)
Hemoglobin (g/dl); median (25th to 75th percentiles); n = 580 11 (10.2 to 11.7)
Serum albumin (g/L); median (25th to 75th percentiles); n = 588 40 (38 to 41)
Urea reduction ratio (%); median (25th to 75th percentiles); n = 572 67 (60 to 72.5)
Biomarkers; median (25th to 75th percentiles)  
Cardiac: Troponin T (ng/ml); n = 481 0.021 (0.009 to 0.051)
NT-proBNP (pg/ml); n = 481 289.2 (137.3 to 651.9)
Inflammatory: C-Reactive protein (mg/L); n = 481 3.47 (1.47 to 8.13)
IL-6 (pg/ml); n = 481 4.39 (2.69 to 8.8)
Leptin (ng/ml); n = 481 12.4 (3.7 to 43.8)
Quality of life domains; median (25th to 75th percentiles)  
SF-36 Physical functioning; n = 457 70 (50 to 85)
SF-36 Vitality; n = 457 55 (40 to 75)
FACIT Fatigue; n = 572 73.1 (57.7 to 86.3)